Slingshot Insights | Pulm Overview

PULM Overview

Upcoming Projects (PULM)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (PULM)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (PULM)

Pulmatrix (PULM) Awarded European Patent Covering iSPERSE Inhaled Drug Delivery Technology for a Range of Diseases
Ticker: PULM
Occurred on: Mar 21, 2017
Pulmatrix Receives Orphan Drug Designation from the FDA for Inhaled Drug to Treat Pulmonary Fungal Infections in Cystic Fibrosis Patients
Ticker: PULM
Occurred on: Aug 17, 2016
Pulmatrix Initiates European Pilot Bioequivalence Study of PUR0200 for COPD; topline results are expected to be reported in the second quarter of 2016
Ticker: PULM
Occurred on: Jul 19, 2016
Pulmatrix and Mylan Report Positive Pharmacokinetic Bioavailability Data in Pilot Study of PUR0200 in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Tickers: PULM, MYL
Occurred on: Jul 19, 2016

Strategic Initiatives (PULM)

Don’t see a strategic initiative related to the company you care about? Create your own!